Back to search
ASA Class III/IV Patients
Clinical trial pipeline · Data from ClinicalTrials.gov
See which ASA Class III/IV Patients trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which ASA Class III/IV Patients trials you may qualify forRemimazolam is a new, ultra-short-acting benzodiazepine approved in Romania for procedural sedation. It shows significant clinical benefits compared to other se…
The study investigates a novel anaesthesiological clinical decision support (CDS) application, that integrates risk evaluation tools and updated clinical guidel…
A phase III confirmatory trial evaluating the efficacy and safety of remimazolam (CNS7056) compared to propofol for intravenous anesthesia during elective surge…
Whether patients with chronic heart failure (CHF) should be anticoagulated is one of the oldest unresolved questions in cardiovascular therapeutics. Some author…